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Abstract Nucleoside di- and triphosphates and adenosine
regulate several components of the mucocilairy clearance
process (MCC) that protects the lung against infections, via
activation of epithelial purinergic receptors. However, assess-
ing the contribution of individual nucleotides to MCC
functions remains difficult due to the complexity of the
mechanisms of nucleotide release and metabolism. Enzymatic
activities involved in the metabolism of extracellular nucleo-
tides include ecto-ATPases and secreted nucleoside diphos-
phokinase (NDPK) and adenyl kinase, but potent and selective
inhibitors of these activities are sparse. In the present study, we
discovered that ebselen markedly reduced NDPK activity
while having negligible effect on ecto-ATPase and adenyl
kinase activities. Addition of radiotracer [γ32P]ATP to human
bronchial epithelial (HBE) cells resulted in rapid and robust
accumulation of [32P]-inorganic phosphate (32Pi). Inclusion
of UDP in the incubation medium resulted in conversion of
[γ32P]ATP to [32P]UTP, while inclusion of AMP resulted in
conversion of [γ32P]ATP to [32P]ADP. Ebselen markedly
reduced [32P]UTP formation but displayed negligible effect
on 32Pi or [32P]ADP accumulations. Incubation of HBE cells
with unlabeled UTP and ADP resulted in robust ebselen-
sensitive formation of ATP (IC50=6.9±2 μM). This NDPK
activity was largely recovered in HBE cell secretions and
supernatants from lung epithelial A549 cells. Kinetic analysis
of NDPK activity indicated that ebselen reduced the Vmax of
the reaction (Ki=7.6±3 μM), having negligible effect on KM
values. Our study demonstrates that ebselen is a potent non-
competitive inhibitor of extracellular NDPK.
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Introduction
Nucleotides and nucleosides within the airway surface
liquid (ASL) regulate key components of the mucociliary
clearance (MCC) process that removes foreign particles and
pathogens from the lung [1–3]. Adenosine-5′-triphosphate
(ATP) and uridine-5′-triphosphate (UTP) activate the Gq-
coupled P2Y2 receptor (P2Y2-R) that promotes mucin
secretion from goblet cells [2]. The P2Y2-R expressed on
ciliated cells, promotes ciliary beat frequency, protein
kinase C-enhanced cystic fibrosis transmembrane conduc-
tance regulator (CFTR)-mediated Cl− secretion, and Ca2+-
activated Cl− channel (CaCC) activity [3]. In addition,
P2Y2-R activation results in inhibition of the epithelial
sodium channel ENaC [3]. UDP promotes CaCC activity
via activation of the P2Y6-R expressed on ciliated cells [3].
Adenosine generated from the hydrolysis of ATP in ASL
activates the Gs-coupled A2B receptor (A2B-R) that pro-
motes cyclic AMP-regulated CFTR activity and increases
cilia beat frequency [3–5]. In the distal lung, ATP/UTP and/
or adenosine (mainly via P2Y2-R and A2B-R, respectively)
stimulate type II cell surfactant secretion [6], regulate
alveolar ion transport and fluid clearance [7, 8], and
contribute to alveolar remodeling and inflammation [9, 10].
Nucleotide/nucleoside levels in ASL and lung secretions
reflect a balance between cellular nucleotide release and
extracellular metabolism [11]. Early studies suggested that
ATP, and to a lesser extent UTP and other nucleoside
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triphosphates (NTPs), are released fromairway epithelial cells
[11–13] and subsequently hydrolyzed to nucleoside di- and
monophosphate (NDP and NMP, respectively) and nucleo-
sides (e.g., adenosine) by action of cell surface NTPDases,
NTP pyrophosphatase, alkaline phosphatase, and 5′-nucleo-
tidase [11, 14, 15]. In addition, NDP kinase (NDPK) and
adenyl kinase provide nucleotide interconversion activities in
ASL [11, 16, 17].
Recently, a mathematical model based on the rates of ATP
release and metabolism and adenosine accumulation rates in
ASL predicted that adenosine-5′-diphosphate (ADP) and/or
monophosphate (AMP) are released from airway epithelial
cells, in addition to ATP [18]. Consistent with this prediction,
we have recently demonstrated the presence of a nucleotide
pool within secretory granules isolated from goblet cells,
which was represented (in abundance order) by ADP>AMP
>>ATP [19]. Direct release of ADP/AMP to ASL would
selectively promote liquid secretion from ciliated cells, via
adenosine formation and A2B-R activation. In addition, our
recent demonstration that airway epithelial and other cells
release UDP-sugars from Golgi-derived vesicles [20] implies
that UDP, which accumulates in the Golgi as product of
UDP-sugar-based glycosylation reactions, is released from
cells via the secretory pathway [21, 22]. Since the P2Y6-R is
expressed on ciliated cells (but not on goblet cells) [2], UDP
release would selectively promote CaCC-mediated electrolyte
transport and ciliary beat frequency without enhancing mucin
secretion.
While ATP, UTP, ADP, UDP, AMP, and adenosine are
naturally occurring molecules in ASL [13, 23–26], assess-
ing the exact contribution of individual nucleotides to MCC
functions remains difficult, due in part to the complexity of
the mechanisms that control nucleotide release and concen-
trations in ASL. In particular, strong NDPK activity has
been reported in conditioned medium from airway epithe-
lial cells [11, 27]. The activity of extracellular NDPK,
which catalyzes transphosphorylation reactions such as the
reversible phosphorylation of UDP by ATP (ATP+UDP=
ADP+UTP), surmounts that of nucleotidases under a
number of conditions. NDPK-catalyzed transphosphorylat-
ing reactions provide a confusing factor in the assessment
of the primary source of ASL nucleotides. Measuring the
rates of release of NTPs, NDPs, and NMPs has been
dampened by the lack of non-nucleotide molecules to
inhibit nucleotide interconversion.
The organoselenium compound ebselen [1, 2-phenyl-1,
2-benzisoselenazol-3(2H)-1] has been reported to inhibit,
albeit partially (∼60% inhibition, <100 μM ebselen), the
hydrolysis of extracellular ATP in rat platelets [28]. More
recently, we have illustrated that ebselen slightly delayed
ATP metabolism on primary cultures of human airway
epithelial cells [25], but the identity of the ATP metaboliz-
ing ecto-activity present in airway epithelia targeted by
ebselen is not known. In the present study, by examining
the effect of ebselen on the metabolism of extracellular ATP
on airway epithelial cells, we discovered that ebselen is a
potent, non-competitive full inhibitor of NDPK.
Materials and methods
Reagents ADP, UDP, 2-phenyl-1, 2-benzisoselenazol-3(2H)-
1 (ebselen), and luciferase from Photinus pyralis were
obtained from Sigma (St. Louis, MO). For experiments
using ebselen derivatives, ebselen and its analogues 2, 2′-
diseleno benzanilide (EbSe2), 2, 2′-ditelluro benzanilide
(EbTe2), 2-methyl seleno benzanilide (EbMe), and 2-benzyl
seleno benzanilide (EbBz) were obtained as previously
described [29]. Luciferin was obtained from BD PharMingen
(Franklin Lakes, NJ). ATP and UTP were purchased from
GE Healthcare (Hillsborough, NC). [γ32P]ATP was obtained
from Amersham Biosciences (Piscataway, NJ). All other
reagents were from sources previously reported [11, 13, 20].
Cell culture and incubations Polarized cultures of well-
differentiated primary HBE cells (provided by the UNC
Cystic Fibrosis Center Center Tissue Culture Core Lab) and
A549 lung epithelial cells were grown on 12-mm Transwell
supports (Costar) and on 24-well plastic plates, respective-
ly, as previously described [13, 25, 30]. The cells were
rinsed and 300 μl serum-free Dulbecco’s modified Eagle’s
medium were added to the mucosal compartment of HBE
cells or to A549 cell culture wells. After a 1 h pre-
incubation period, cell cultures where incubated with drugs,
as indicated below. Alternatively, pre-incubation medium
was collected, centrifuged, and the supernatant used within
2 h to assess nucleotide metabolism activities in condi-
tioned medium. Incubations were initiated by the addition
of the indicated reagent to cultures or to 100-μl conditioned
medium. After the desired incubation time at 37°C, samples
from cultures and conditioned medium were heated for
2 min at 95°C to inactivate enzyme activities.
NDPK and adenyl kinase activities NDPK catalyzes the
reversible phosphorylation of NDPs by NTPs, while adenyl
kinase catalyzes the reversible phosphorylation of AMP by
ATP. NDPK activity was assessed via two alternative
protocols, (reaction 1) as a function of UDP-dependent
conversion of [γ32P]ATP to [32P]UTP, or (reaction 2) as a
function of UTP- and ADP-dependent formation of ATP:
Reaction 1 : g32P
 
ATPþ UDP Ð ADPþ 32P UTP
Reaction 2 : UTPþ ADP Ð UDPþ ATP
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Adenyl kinase activity was assessed either as a function
of AMP-dependent conversion of [γ32P]ATP to [32P]ADP
(reaction 3) or as a function of ADP conversion to ATP
(reaction 4):
Reaction 3 : g32P
 
ATPþ AMP Ð 2ADP þ 32P ADP
Reaction 4 : 2ADP Ð AMPþ ATP
The resulting 32P-labeled species were quantified by
high-performance liquid chromatography (HPLC). ATP
mass formation was assessed by the luciferin/luciferase
assay. In experiments where NDPK activity was assessed as
a function of UTP-dependent phosphorylation of ADP
(reaction 2), ATP formation values obtained in the absence
of UTP (as in reaction 4) were subtracted from those
obtained in the presence of UTP.
HPLC analysis [32P]ATP, [32P]UTP, [32P]ADP, and 32P-
inorganic phosphate (32Pi) were separated by HPLC
(Shimatzu) using 10-μm Hamilton PRP-X100 anion ex-
change column. The mobile phase (1 ml/min; 30%
methanol, solvent A; 0.5 M NH4HCO3 (pH 8.5) in 30%
methanol, solvent B) developed as follows: 75% A and
25% B from 0 to 5 min, 33% A and 67% B from 5 to
15 min, and the column was re-equilibrated to the initial
conditions for additional 10 min. 32P-species were quanti-
fied on-line with a FLO-ONE 500TR Radiomatic analyzer
(Packard), as described previously [11].
Measurement of ATP mass ATP measurements were per-
formed via a LB953 AutoLumat luminometer (Berthold), as
previously described [11]. Calibration curves were generat-
ed at the end of each experiment, using known concen-
trations of ATP. None of the reagents used during
incubations interfered with the luciferase reaction.
Data analysis Kinetic parameters from substrate concen-
tration–response relationships and inhibition constants were
calculated using Sigma Plot v.10 data fitting analysis.
Results
Ebselen inhibits the UDP-dependent conversion of [γ32P]
ATP to [32P]UTP on WD-HBE cells The fate of trace
amounts of [γ32P]ATP added to the mucosal medium
bathing WD-HBE cell cultures was assessed by HPLC.
Addition of [γ32P]ATP to cells resulted in rapid and robust
release (∼50% after 3 min) of the radiolabel as 32Pi (Fig. 1a
(i and ii)). ATP hydrolysis was not affected by the inclusion
of 30 μM ebselen in the incubation mix (Fig. 1a (iii)).
Previously, we reported the presence of ecto-NDPK activity
on various cell types, including airway epithelial cells [11,
27, 31]. Consistent with these reports, addition of radio-
tracer [γ32P]ATP and excess mass of UDP (10 μM UDP) to
WD-HBE cells resulted in the formation of [32P]UTP
(Fig. 1a (iv)). The conversion of [γ32P]ATP to [32P]UTP
was markedly reduced by the presence of 30 μM ebselen
(Fig. 1a (v)).
Ebselen-sensitive NDPK activity is recovered in the
conditioned medium ATP hydrolysis on airway epithelial
cells reflected the action of cell surface ecto-ATPases [11].
Accordingly, release of 32Pi from [γ32P]ATP was rapid and
robust when the radiotracer was added to cells, but was
negligible in the WD-HBE cell-conditioned medium
(Fig. 1b (i)). Consistent with the data in Fig. 1a, ebselen
had no effect on [γ32P]ATP hydrolysis (Fig. 1b (i)). In
contrast to ATPase activity, NDPK activity could be
substantially recovered as a soluble enzyme, i.e., in the
cell conditioned medium (Fig. 1b (ii), and [11]). Ebselen
(30 μM) markedly reduced the conversion of [γ32P]ATP to
[32P]UTP (Fig. 1b (ii)).
In addition to NTPDase and NDPK activities, airway
epithelia express ecto-adenyl kinase activity [16, 17], which
reversibly phosphorylates AMP (as described above in
reaction 3). Addition of [γ32P]ATP together with 10 μM
AMP resulted in rapid formation of [32P]ADP on both WD-
HBE cell cultures and cell-conditioned medium (Fig. 1b (iii)).
The adenyl kinase activity was markedly less robust than the
NDPK activity and was not affected by ebselen (Fig. 1b (iii)).
Altogether, the data indicate that NDPK activity (1) is
markedly inhibited by ebselen and (2) can be assessed in
cell-free-conditioned medium.
Ebselen inhibits the UTP-dependent conversion of ADP to
ATP To further investigate the action of ebselen on NDPK
activity, we adopted a non-radioactive protocol that
quantifies the formation of ATP as a function of UTP and
ADP in conditioned medium (see reaction 2 in “Materials
and methods”). Conditioned medium from WD-HBE cell
cultures contains low nanomolar concentrations of ATP
(∼6 nM, Fig. 2a), which reflects the presence of endoge-
nous ATP released from cells [13]. Addition of 10 μM ADP
in the absence of UTP resulted in formation of ATP
(∼50 nM ATP, Fig. 2a), consistent with an adenyl kinase-
catalyzed reaction (see reaction 4 in “Materials and
methods”). The ADP-dependent ATP formation (observed
in the absence of exogenous UTP) was not affected by
ebselen (Fig. 2a). Addition of 10 μM UTP to the medium in
the absence of exogenous ADP resulted in minor ebselen-
sensitive formation of ATP (∼20 nM ATP, Fig. 2a), likely
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reflecting phosphorylation of endogenous ADP by NDPK.
Furthermore, a marked formation of ATP (∼200 nM) was
observed when UTP and ADP were added together
(Fig. 2a). Formation of ATP in the presence of both UTP
and ADP was nearly abolished by ebselen (Fig. 2a).
Figure 2b indicates that ebselen dose-dependently inhibited
NDPK activity in WD-HBE cell secretions, displaying an
IC50 value of 6.9±2 μM.
Ebselen is a potent, non-competitive inhibitor of NDPK To
characterize in greater detail the nature of ebselen
inhibition on NDPK, conditioned medium from lung
epithelial A549 cells was obtained. We chose using this
fast-growing cell line as a source of secreted NDPK to
bypass the limitations inherent to the low availability of
primary cultures of HBE cells. Thus, protocols described
above were adapted to non-polarized cultures of lung
epithelial A549 cells. An initial assessment indicated
that, like primary HBE cells, the conditioned medium of
A549 cells displays robust NDPK activity that catalyzes
the phosphorylation of UDP (10 μM) by [γ32P]ATP in an
ebselen-sensitive manner (Fig. 3). Also like in HBE cells,
[γ32P]ATP hydrolysis by A549 cell-conditioned medium
was minor (<20% 32Pi accumulation) and only slightly
affected by ebselen (Fig. 3).
Next, the effect of ebselen on the substrate concen-
tration dependence for UTP- and ADP-promoted forma-
tion of ATP was assessed. Figure 4a illustrates the effect
of UTP concentration on ATP formation, using 20 μM
ADP as acceptor substrate for the NDPK activity present
in the A549 cell-conditioned medium. In the absence of
ebselen, the reaction displayed an apparent KM value of
18 μM UTP, and maximal ATP formation (6.8 μM/
10 min) occurred with an apparent Vmax=68±6 pmoles/
min. Ebselen dose-dependently decreased the Vmax of the
reaction (Fig. 4a) while displaying a minor effect on the
Fig. 1 Ebselen inhibits the UDP-dependent conversion of [γ32P]ATP to
[32P]UTP on WD-HBE cells. HPLC analysis of [γ32P]ATP metabolism
on WD-HBE cells. Radiotracer [γ32P]ATP (∼0.1 μCi) was added to
cultures (mucosal addition) and the resulting [32P]-labeled species
separated and analyzed by HPLC, as indicated in “Materials and
methods”. a Representative HPLC tracings (n=4) corresponding to
samples incubated for T=0 min (i), or 3 min in the presence of vehicle
(ii), 30 μM ebselen (Ebs) (iii), 10 μM UDP (iv), or 30 μM ebselen and
10 μM UDP (v). The tracings represent the radioactivity (cpm) eluting
from the HPLC column, recorded at 10-s intervals. b [γ32P]ATP alone
(i), [γ32P]ATP and 10 μM UDP (ii), or [γ32P]ATP and 10 μM AMP (iii)
was added to cell cultures or to conditioned medium (Con. medium) for
the indicated times, and the formation of 32Pi (i), [32P]UTP (ii), and
[32P]ADP (iii) were quantified by HPLC (mean ± SD from two
experiments performed in triplicates). The results are expressed as
percent conversion of [32P]ATP to [32P]-product, relative to T=0”. The
area of each radioactive peak was calculated using the HPLC analysis
software provided by the manufacturer
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UTP KM value (Table 1). ADP concentration–effect
relationships generated in the presence of 100 μM UTP
indicated KM and Vmax values of 1.3 μM and 47+
4 pmoles/min, respectively (Fig. 4b and Table 1). Ebselen
reduced the Vmax (Fig. 4b) but had no effect on the ADP
KM value (Table 1). The data suggest that ebselen behaves
as a non-competitive inhibitor. Dixon Plot analysis [32] of
the data indicated a Ki value for ebselen-inhibited NDPK
activity of 7.6±3 μM. In the absence of exogenous UTP,
some ATP formation was observed, which was likely
mediated by adenyl kinase and represented approximately
5% of that attained in the presence of 100 μM UTP
(compare Figs. 4c vs. 4b). In contrast to the robust
inhibition of NDPK activity, ebselen (30 μM) had
negligible effect on the adenyl kinase-mediated formation
of ATP (Fig. 4c).
Several ebselen derivatives have been recently used to
assess the redox properties of selenium compounds [29].
Concentration–effect curves generated for a series of ebselen
analogues indicated that the organotellurium EbTe2 reduced
UTP-dependent formation of ATP in conditioned medium,
but the inhibitory effect of EbTe2 on ATP formation was
markedly weaker than that of ebselen (Fig. 5). Se-methylated
(EbMe) and Se-benzylated (EbBz) derivatives of ebselen and
the diselenide EbSe2 had negligible effect on ATP formation
(Fig. 5). These results were consistent with the notion that
structural modification in organoselenium compounds alter
their redox activities [29].
Discussion
Our present study demonstrates that ebselen is a potent
non-competitive inhibitor of NDPK. NDPK (also known as
Nm23) is a housekeeping enzyme catalyzing the phosphor-
ylation of NDPs, utilizing NTPs as terminal phosphate
donor. Intracellular NDPK fulfills a crucial role in main-
taining the high energy phosphate bond in ATP as part of
the citric acid chain. NDPK also has been proposed to play
a major role in maintaining a relative balance in the
concentrations of cellular NTPs. In addition to its central
role in cellular metabolism, NDPK is released from cells to
catalyzed transphosphorylation reactions between extracel-
lular nucleotides. Robust NDPK activity has been reported
in conditioned medium from astrocytes, glioma, and airway
Fig. 3 Ebselen inhibits the phosphorylation of UDP in conditioned
medium from A549 cells. A549 cell-conditioned medium was
incubated with [γ32P]ATP in the absence (control) or presence of
10 μM UDP. The percent conversion of [γ32P]ATP to 32Pi or [32P]
UTP was assessed as in Fig. 1. Ebselen (30 μM) or vehicle was added
to samples 1 min prior incubations, as indicated. The data represent
the mean (±SD) from two experiments performed in triplicate
Fig. 2 Ebselen inhibits the UTP-dependent phosphorylation of ADP
in conditioned medium from WD-HBE cells. a Conditioned medium
from WD-HBE cells was incubated for 5 min with either vehicle or
30 μM ebselen in the absence (control) or presence of 10 μM ADP
and/or 10 μM UTP. The formation of ATP was assessed by the
luciferin–luciferase assay, as described in Methods. b Concentration–
effect relationship for ebselen-inhibited UTP-dependent ATP forma-
tion (mean ± SD, n=4); ATP values obtained in the absence of UTP
were subtracted from the corresponding ADP/UTP data point
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epithelial cells, endothelial cells, osteoblasts, and keratino-
cytes [11, 31, 33–35].
Local transphosporylation complicates the task of accu-
rately quantifying nucleotide concentrations at the cell
surface upon release. For example, Buxton et al. [33]
reported the involvement of bradykinin receptors in the
release of ATP in coronary endothelium and also illustrated
that although application of ADP resulted in an increase in
ATP levels, this likely occurred as a consequence of
phosphorylation of ADP by NDPK rather than stimulation
of P2Y1 receptors. Bradykinin and phenylephrine promoted
ATP release in Madin–Darby canine kidney, simian COS-7,
and human embryonic kidney (HEK)-293 cells [36]. UTP
also enhanced extracellular ATP accumulation in COS-7
and HEK-293 cells, but the effect of UTP probably
reflected competitive inhibition of ATP hydrolysis and
phosphorylation of endogenous ADP by NDPK rather than
P2Y2 receptor-stimulated ATP release [36]. In a study
designed to investigate the potential role of connexin
hemichannels in ATP release, Cotrina et al. reported that
stimulation of purinergic receptors with 100 μM UTP in
HeLa cells, C6 glioma cells, and U373 glioblastoma cells
Fig. 5 Effect of ebselen derivatives on the UTP- and ADP-dependent
formation of ATP. A549 cell-conditioned medium was incubated for
5 min at 37°C in the presence of 60 μM UTP, 20 μM ADP, and the
indicated concentration of ebselen or ebselen derivative. The data
represent the percent value (mean ± SD, n=4) relative to the ATP
formation observed in the obscene of inhibitor
Fig. 4 ATP formation as a function of substrate concentration. Effect
of ebselen. Concentration–effect relationships for UTP- and ADP-
dependent formation of ATP were established in A549 cell-
conditioned medium. a UTP concentration vs. ATP formation was
assessed in the presence of 20 μM ADP and the indicated
concentration of ebselen. b ADP concentration vs. ATP formation in
the presence of 100 μM UTP and the indicated concentration of
ebselen. c Eebselen (30 μM) exhibited negligible effect on the ADP-
dependent ATP formation in the absence of exogenous UTP. The data
represent the mean (±SD) from one experiment performed in
triplicate; similar results were obtained with three independent
preparations of A549 cells. ATP values observed in the absence of
UTP [as shown in (c)] were subtracted from the corresponding ADP/
UTP data point in (a) and (b). All incubations were for 10 min at 37°C
Table 1 Effect of ebselen on KM values for the UTP-dependent
phosphorylation of ADP in A549 cell secretions







Concentration–effect relationships for UTP- and ADP-promoted ATP
formation were established in A549 cell-conditioned medium incu-
bated for 5 min in the presence of the indicated concentration of
ebselen, as described in Fig. 4
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resulted in a Ca2+-dependent increase of extracellular ATP
concentrations. However, other Ca2+-mobilizing agents
such as bradykinin, endothelin, and the calcium ionophore
A2317 had little or no effect on extracellular ATP levels
[37]. Because the likely contribution of NDPK in the
phosphorylation of endogenous ADP was not examined,
the significance of the ATP measurements in response to
exogenous UTP remains unclear. Our present finding that
ebselen inhibits NDPK activity provides a tool to assess the
potential contribution of NDPK to nucleotide-promoted
ATP release.
It has been previously reported that ebselen exhibits both
glutathione peroxidase activity and antioxidant activity and
that ebselen inhibits several redox-sensitive enzymes such as
constitutive endothelial nitric oxide synthase, lipoxygenases,
nicotinamide adenine dinucleotide phosphate oxidase, and
other activities (Table 2 and [29, 38–43]). Furthermore,
organoselenium compounds in the form of seleninic acids
can couple with thiols on catalytically important cysteine
residues (e.g., of phosphotyrosine phosphatase), resulting in
enzyme inhibition [44]. It has been suggested that cysteine
residues sensitive to redox conditions are involved in the
functional regulation of NDPK [45]. Our data indicating that
structural modifications affecting the redox properties of the
organoselenium compound resulted in reduced NDPK
inhibition (Fig. 5) are consistent with the notion that
oxidative modifications regulate NDPK functions.
Two functionally active human NDPK isoenzymes have
been characterized: NDPK-A (Nm23-H1) and NDPK-B
(Nm23-H2) [46, 47]. In addition, four putative additional
NDPK genes have been identified: DR-nm23, nm23-H4,
nm23-H5, and nm23-H6, however, the presence of NDP
kinase activity in these gene products has not been
unambiguously demonstrated [48–51].
Recent studies with guinea pig endothelial cells and
human breast carcinoma MDA-MB-435 cells have
identified NDPK-A and NDPK-B as the major NDPK
enzymes secreted from these cells, respectively [33, 52].
Whether NDPK-A, NDPK-B, or both are released from
lung epithelial cells and what is the physiological role of
such an activity remains to be elucidated. However, an
important role of secreted NDPK may reside in regulating
purinergic signaling, by affecting the extracellular con-
centrations of ATP, ADP, UTP, and UDP [31, 33, 53]. By
regulating ATP levels locally, secreted NDPK-B supports
angiogenesis, via endothelial cell P2Y receptor activation
[52]. The mechanism of NDPK secretion is not under-
stood. Based on the lack of secretion signal sequence of
NDPK-A and NDPK-B, it has been proposed that NDPK
may be secreted via non-classical export mechanisms
similar to those involved in the release of fibroblast
growth factors 1 and 2 [52].
Irrespective of the NDPK release mechanism, identifi-
cation of potent and selective NDPK inhibitors would be
relevant to studies of P2Y and P2X receptors and,
potentially, may provide useful in elucidating the role of
secreted NDPKs in angiogenesis and tumor development.
Previously, cyclic AMP analogues were shown to inhibit
NDPK activity, with IC50 values in the 100–500 μM range
[54]. More recently, angiostatin (a proteolytic fragment of
plasminogen), polyphenols, and adenosine 3′-phosphate 5′-
phosphosulfate were shown to inhibit secreted NDPK-B,
but only one of these compounds, ellagic acid, displayed
inhibitory effect in the low micromolar concentration range
(IC50∼10 μM [55]).
By illustrating that ebselen non-competitively inhibits
extracellular lung epithelial cell NDPK activity with a
<10 μM Ki value, our present study suggest a valuable tool
to assess the contribution of nucleotide release to lung
epithelial cell functions. In addition, while ebselen has
broad substrate selectivity, it may be a candidate structure
for the development of highly potent and selective NDPK
inhibitors useful to studies of the physiological consequen-
ces of extracellular NDPK activity.
Activity IC50 (μM) Reference
NOS 8.5 38
15-Lipoxygenase 0.17 39
Prostaglandin endoperoxide synthase-1 37.7 39
NADPH oxidase 0.5–1.0 40
PKC (partially purified) 1.0 40
Phorbol ester-stimulated PKC in intact cells 50 40
Horseradish peroxidase 16.9 29
Lipid peroxidation 2.5 29
Yeast plasma membrane H+-ATPase 4.5 42
Yeast growth 2–5 43
DMT1-mediated iron uptake 0.2 41
Table 2 Ebselen inhibits
various biological activities
NOS nitric oxide synthase, PKC
protein kinase C, DMT1 divalent
metal transporter-1
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